Oral leukoplakia


Key articles

Reibel J. Prognosis of oral premalignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14(1):47-62.Full text  Abstract

Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med. 1995;6(2):147-60. Abstract

Reference articles

1. Kramer IR, Lucas RB, Pindborg JJ, et al. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978 Oct;46(4):518-39. Abstract

2. Axell T, Holmstrup P, Kramer IRH, et al. International seminar on oral leukoplakia and associated lesions related to tobacco habits. Community Dent Oral Epidemiol. 1984 June;12(3):145-54.

3. Axell T, Pindborg JJ, Smith CJ, et al. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med. 1996 Feb;25(2):49-54. Abstract

4. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov;36(10):575-80. Abstract

5. Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol. 1986 Apr;61(4):373-81. Abstract

6. Mehta FS, Pindborg JJ, Gupta PC, et al. Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer. 1969 Oct;24(4):832-49. Abstract

7. Mehta, FS, Gupta PC, Daftary PK, et al. An epidemiologic study of oral cancer and precancerous conditions among 101,761 villagers in Maharashtra, India. Int J Cancer. 1972 Jul;10(1):134-41. Abstract

8. Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis. 1987 Oct;8(10):1543-48. Abstract

9. Baric JM, Altman JE, Feldman RS, et al. Influence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surg Oral Med Oral Pathol. 1982 Oct;54(4):424-9. Abstract

10. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215. Abstract

11. Liu W, Shen XM, Liu Y, et al. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases. J Oral Pathol Med. 2011 Apr;40(4):312-6. Abstract

12. Staines K, Rogers H. Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners. Br Dent J. 2017 Dec;223(9):655-661.Full text  Abstract

13. Poh CF, Zhang L, Lam WL, et al. A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest. 2001 Apr;81(4):629-34. Abstract

14. Reibel J. Prognosis of oral premalignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14(1):47-62.Full text  Abstract

15. Kawanishi S, Hiraku Y, Pinlaor S, et al. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-mediated carcinogenesis. Biol Chem. 2006 Apr;387(4):365-72. Abstract

16. Zhang L, Rosin MP. Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med. 2001 Oct;30(9):513-20. Abstract

17. Warnakulasuriya S, Reibel J, Bouquot J, et al. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008 Mar;37(3):127-33.Full text  Abstract

18. Thomas G, Hashibe M, Jacob BJ, et al. Risk factors for multiple oral premalignant lesions. Int J Cancer. 2003 Nov 1;107(2):285-91. Abstract

19. Dietrich T, Reichart PA, Scheifele C. Clinical risk factors of oral leukoplakia in a representative sample of the US population. Oral Oncol. 2004 Feb;40(2):158-63. Abstract

20. Fisher MA, Bouquot JE, Shelton BJ. Assessment of risk factors for oral leukoplakia in West Virginia. Community Dent Oral Epidemiol. 2005 Feb;33(1):45-52. Abstract

21. Jaber MA, Porter SR, Scully C, et al. Role of alcohol in non-smokers and tobacco in non-drinkers in the aetiology of oral epithelial dysplasia. Int J Cancer. 1998 Jul;77(3):333-6. Abstract

22. Warnakulasuriya S, Parkkila S, Nagao T, et al. Demonstration of ethanol-induced protein adducts in oral leukoplakia (pre-cancer) and cancer. J Oral Pathol Med. 2008 Mar;37(3):157-65. Abstract

23. Piscopo M, Campisi G, Colella G, et al. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia. Oral Dis. 2006 Mar;12(2):130-6. Abstract

24. Petti S, Scully C. Association between different alcoholic beverages and leukoplakia among non- to moderate-drinking adults: a matched case-control study. Eur J Cancer. 2006 Mar;42(4):521-7. Abstract

25. Maserejian NN, Joshipura KJ, Rosner BA, et al. Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):774-81.Full text  Abstract

26. Jacob BJ, Straif K, Thomas G, et al. Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol. 2004 Aug;40(7):697-704. Abstract

27. Yen AM, Chen SC, Chang SH, et al. The effect of betel quid and cigarette on multistate progression of oral pre-malignancy. J Oral Pathol Med. 2008 Aug;37(7):417-22. Abstract

28. Ariyawardana A, Sitheeque MA, Ranasinghe AW, et al. Prevalence of oral cancer and pre-cancer and associated risk factors among tea estate workers in central Sri Lanka. J Oral Pathol Med. 2007 Nov;36(10):581-7. Abstract

29. Takeshima M, Saitoh M, Kusano K, et al. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka. J Oral Pathol Med. 2008 Sept;37(8):475-9. Abstract

30. Hsieh CH, Chang JW, Hsieh JJ, et al. Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area. Head Neck. 2011 Dec;33(12):1758-64. Abstract

31. Krogh P, Holmstrup P, Thorn JJ, et al. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol. 1987 Jan;63(1):48-54. Abstract

32. Krogh P, Holmstrup P, Vedtofte P, et al. Yeast organisms associated with human oral leukoplakia. Acta Derm Venereol Suppl (Stockh). 1986 Jan;63(1):51-5. Abstract

33. Holmstrup P, Bessermann M. Clinical, therapeutic, and pathogenic aspects of chronic oral multifocal candidiasis. Oral Surg Oral Med Oral Pathol. 1983 Oct;56(4):388-95. Abstract

34. Barrett AW, Kingsmill VJ, Speight PM. The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Dis. 1998 Mar;4(1):26-31. Abstract

35. Majumder M, Sikdar N, Paul RR, et al. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among workers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280). Cancer Epidemiol Biomarkers Prev. 2005 Sept;14(9):2106-12.Full text  Abstract

36. Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):582-590.Full text  Abstract

37. King GN, Healy CM, Glover MT, et al. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol. 1994 Dec;78(6):718-26. Abstract

38. Hernandez G, Arriba L, Jimenez C, et al. Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient. Oral Oncol. 2003 Jan;39(1):87-90. Abstract

39. Alter B. Aplastic anemia, pediatric aspects. Oncologist. 1996;1(6):361-6.Full text  Abstract

40. Tanaka A, Kumagai S, Nakagawa K, et al. Cole-Engman syndrome associated with leukoplakia of the tongue: a case report. J Oral Maxillofac Surg. 1999 Sept;57(9):1138-41. Abstract

41. Tekcicek M, Tavil B, Cakar A, et al. Oral and dental findings in children with Fanconi anemia. Pediatr Dent. 2007 May-Jun;29(3):248-52. Abstract

42. Hakansson N, Floderus B, Gustavsson P, et al. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology. 2001 Sept;12(5):552-7. Abstract

43. Perea-Milla Lopez E, Minarro-Del Moral RM, Martinez-Garcia C, et al. Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain. Br J Cancer. 2003 Jun 2;88(11):1702-7.Full text  Abstract

44. Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control. 1996 Jul;7(4):458-63. Abstract

45. Eversole LR. Papillary lesions of the oral cavity: relationship to human papillomaviruses. J Calif Dent Assoc. 2000 Dec;28(12):922-7. Abstract

46. Sand L, Jalouli J, Larsson PA, et al. Human papilloma viruses in oral lesions. Anticancer Res. 2000 Mar-Apr;20(2B):1183-8. Abstract

47. Cianfriglia F, Di Gregorio DA, Cianfriglia C, et al. Incidence of human papillomavirus infection in oral leukoplakia: indications for a viral aetiology. J Exp Clin Cancer Res. 2006 Mar;25(1):21-8. Abstract

48. Dickenson AJ, Currie WJ, Avery BS. Screening for syphilis in patients with carcinoma of the tongue. Br J Oral Maxillofac Surg. 1995 Oct;33(5):319-20. Abstract

49. Michalek AM, Mahoney MC, McLaughlin CC, et al. Historical and contemporary correlates of syphilis and cancer. Int J Epidemiol. 1994 Apr;23(2):381-5. Abstract

50. Petti S, Scully C. The role of the dental team in preventing and diagnosing oral cancer: 5. Alcohol and the role of the dentist in alcohol cessation. Dent Update. 2005 Oct;32(8):454-5, 458-60, 462. Abstract

51. Shiu MN, Chen TH. Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev. 2004 Feb;13(1):39-45. Abstract

52. Sankaranarayanan R, Fernandez Garrote L, Lence Anta J, et al. Visual inspection in oral cancer screening in Cuba: a case-control study. Oral Oncol. 2002 Feb;38(2):131-6. Abstract

53. Shugars DC, Patton LL. Detecting, diagnosing, and preventing oral cancer. Nurse Pract 1997 Jun;22(6):105, 109-10, 113-5. Abstract

54. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer. 1975 Oct;36(4):1386-92. Abstract

55. Wright JM. Oral precancerous lesions and conditions. Semin Dermatol. 1994 Jun;13(2):125-31. Abstract

56. Jaber MA, Porter SR, Gilthorpe MS, et al. Risk factors for oral epithelial dysplasia - the role of smoking and alcohol. Oral Oncol. 1999 Mar;35(2):151-6. Abstract

57. Sankaranarayanan R. Screening for cervical and oral cancers in India is feasible and effective. Natl Med J India. 2005 Nov-Dec;18(6):281-4. Abstract

58. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin. 1995 Nov-Dec;45(6):328-51.Full text  Abstract

59. Liu W, Wang YF, Zhou HW, et al. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010 Dec 16;10:685.Full text  Abstract

60. Yanik EL, Katki HA, Silverberg MJ, et al. Leukoplakia, oral cavity cancer risk, and cancer survival in the US elderly. Cancer Prev Res (Phila). 2015 Sept;8(9):857-63. Abstract

61. Massano J, Regateiro FS, Januario G, et al. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):67-76. Abstract

62. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953 Sept;6(5);963-8. Abstract

63. Braakhuis BJ, Brakenhoff RH, Leemans CR. Head and neck cancer: molecular carcinogenesis. Ann Oncol. 2005;16(suppl 2):ii249-50.Full text  Abstract

64. Braakhuis BJ, Leemans CR, Brakenhoff RH. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol. 2005 Apr;15(2):113-20. Abstract

65. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res. 2004 Jun 1;10(11):3607-13.Full text  Abstract

66. Braakhuis BJ, Tabor MP, Kummer JA, et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003 Apr 16;63(8):1727-30.Full text  Abstract

67. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989 Sept;17(3):691-4. Abstract

68. Silverman S Jr. Early diagnosis of oral cancer. Cancer. 1988 Oct 15;62(suppl 8):1796-9. Abstract

69. Mashberg A, Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am J Surg. 1988 Oct;156(4):273-5. Abstract

70. Scully C, Malamos D, Levers BG, et al. Sources and patterns of referrals of oral cancer: role of general practitioners. Br Med J (Clin Res Ed). 1986 Sept 6;293(6547):599-601.Full text  Abstract

71. Dimitroulis G, Reade P, Wiesenfeld D. Referral patterns of patients with oral squamous cell carcinoma, Australia. Eur J Cancer B Oral Oncol. 1992 Jul;28B(1):23-7. Abstract

72. Chiesa F, Sala L, Costa L, et al. Excision of oral leukoplakias by CO2 laser on an outpatient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori. 1986 Jun 30;72(3):307-12. Abstract

73. Holmstrup P, Vedtofte P, Reibel J, et al. Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med. 2007 May;36(5):262-6. Abstract

74. Califano J, Westra WH, Meininger G, et al. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res. 2000 Feb;6(2):347-52.Full text  Abstract

75. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Aug;80(2):188-91. Abstract

76. Karabulut A, Reibel J, Therkildsen MH, et al. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med. 1995 May;24(5):198-200. Abstract

77. Fischer DJ, Epstein JB, Morton TH, et al. Interobserver reliability in the histopathologic diagnosis of oral premalignant and malignant lesions. J Oral Pathol Med. 2004 Feb;33(2):65-70. Abstract

78. Fischer DJ, Epstein JB, Morton TH Jr, et al. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncol. 2005 May;41(5):489-96. Abstract

79. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006 Mar;42(3):229-39. Abstract

80. Lathanasupkul P, Poomsawat S, Punyasingh J. A clinicopathologic study of oral leukoplakia and erythroplakia in a Thai population. Quintessence Int. 2007 Sept;38(8):e448-55. Abstract

81. Kuffer R, Lombardi T. Premalignant lesions of the oral mucosa: a discussion about the place of oral intraepithelial neoplasia (OIN). Oral Oncol. 2002 Feb;38(2):125-30. Abstract

82. Rethman M, Carpenter W, Cohen EE, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010 May;14(5):509-20. Abstract

83. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009 Jan 30;1:5.Full text  Abstract

84. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions: computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc. 1999 Oct;130(10):1445-57. Abstract

85. Scheifele C, Schmidt-Westhausen A, Dietrich T, et al. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol. 2004 Sept;40(8):824-8. Abstract

86. Svirsky JA, Burns JC, Carpenter WM, et al. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent. 2002 Nov-Dec;50(6):500-3. Abstract

87. Kosicki DM, Riva C, Pajarola GF, et al. Oral CDx brush biopsy - a tool for early diagnosis of oral squamous cell carcinoma [in German]. Schweiz Monatsschr Zahnmed. 2007;117(3):222-7. Abstract

88. Poate TW, Buchanan JA, Hodgson TA, et al. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol. 2004 Sept;40(8):829-34. Abstract

89. Remmerbach TW, Weidenbach H, Hemprich A, et al. Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: report on four cases. Anal Cell Pathol. 2003;25(4):159-66. Abstract

90. Potter TJ, Summerlin DJ, Campbell JH. Oral malignancies associated with negative transepithelial brush biopsy. J Oral Maxillofac Surg. 2003 Jun;61(6):674-7. Abstract

91. Scheifele C, Schlechte H, Bethke G, et al. Detection of TP53-mutations in brush biopsies from oral leukoplakias [in German]. Mund Kiefer Gesichtschir. 2002 Nov;6(6):410-4. Abstract

92. Remmerbach TW, Mathes SN, Weidenbach H, et al. Noninvasive brush biopsy as an innovative tool for early detection of oral carcinomas [in German]. Mund Kiefer Gesichtschir. 2004 Jul;8(4):229-36. Abstract

93. Maraki D, Becker J, Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med. 2004 Aug;33(7):398-404. Abstract

94. Remmerbach TW, Weidenbach H, Muller C, et al. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol. 2003;25(3):139-46. Abstract

95. Zhang L, Cheung KJ Jr, Lam WL, et al. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer. 2001 Jun 1;91(11):2148-55. Abstract

96. de Vicente JC, Rodrigo JP, Rodriguez-Santamarta T, et al. Podoplanin expression in oral leukoplakia: tumorigenic role. Oral Oncol. 2013 Jun;49(6):598-603. Abstract

97. Patel V, Leethanakul C, Gutkind JS. New approaches to the understanding of the molecular basis of oral cancer. Crit Rev Oral Biol Med. 2001;12(1):55-63. Abstract

98. Bremmer JF, Brakenhoff RH, Broeckaert MA, et al. Prognostic value of DNA ploidy status in patients with oral leukoplakia. Oral Oncol. 2011 Oct;47(10):956-60. Abstract

99. Khanna R, Agarwal A, Khanna S, et al. S-phase fraction and DNA ploidy in oral leukoplakia. ANZ J Surg. 2010m Jul-Aug;80(7-8):548-51. Abstract

100. Liu W, Zheng W, Xie J, et al. Identification of genes related to carcinogenesis of oral leukoplakia by oligo cancer microarray analysis. Oncol Rep. 2011 Jul;26(1):265-74. Abstract

101. Swinson B, Jerjes W, El-Maaytah M, et al. Optical techniques in diagnosis of head and neck malignancy. Oral Oncol. 2006 Mar;42(3):221-8. Abstract

102. Suhr MA, Hopper C, Jones L, et al. Optical biopsy systems for the diagnosis and monitoring of superficial cancer and precancer. Int J Oral Maxillofac Surg. 2000 Dec;29(6):453-7. Abstract

103. Sharwani A, Jerjes W, Salih V, et al. Assessment of oral premalignancy using elastic scattering spectroscopy. Oral Oncol. 2006 Apr;42(4):343-9. Abstract

104. Westra WH, Sidransky D. Fluorescence visualization in oral neoplasia: shedding light on an old problem. Clin Cancer Res. 2006 Nov 15;12(22):6594-7.Full text  Abstract

105. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000 Feb;6(2):357-62.Full text  Abstract

106. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg. 2007 Mar;65(3):424-6. Abstract

107. Epstein JB, Gorsky M, Lonky S, et al. The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dentist. 2006 Jul-Aug;26(4):171-4. Abstract

108. Lane PM, Gilhuly T, Whitehead P, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006 Mar-Apr;11(2):024006. Abstract

109. Poh CF, Ng SP, Williams PM, et al. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck. 2007 Jan;29(1):71-6. Abstract

110. Poh CF, Zhang L, Anderson DW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res. 2006 Nov 15;12(22):6716-22.Full text  Abstract

111. Kramer IR. Oral leukoplakia. J R Soc Med. 1980 Nov;73(11):765-7.Full text  Abstract

112. Pindborg JJ, Roed-Petersen B, Renstrup G. Role of smoking in floor of mouth leukoplakias. J Oral Pathol. 1972;1(1):22-9. Abstract

113. Cawson RA. Leukoplakia and oral cancer. Proc R Soc Med. 1969 Jun;62(6):610-4.Full text  Abstract

114. Ismail SB, Kumar SKS, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci. 2007 Jun;49(2):89-106.Full text  Abstract

115. Lopez-Labady J, Viaalrroel-Dorrego M, Gonzalez N, et al. Oral manifestations of systemic and cutaneous lupus erythematosus in a Venezuelan population. J Oral Pathol Med. 2007 Oct;36(9):524-7. Abstract

116. Burge SM, Frith PA, Juniper RP, et al. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol. 1989 Dec;121(6):727-41. Abstract

117. Karjalainen TK, Tomich CE. A histopathologic study of oral mucosal lupus erythematosus. Oral Surg Oral Med Oral Pathol. 1989 May;67(5):547-54. Abstract

118. Serpico R, Pannone G, Santoro A, et al. Report of a case of discoid lupus erythematosus localized to the oral cavity: immunofluorescence findings. Int J Immunopathol Pharmacol. 2007 Jul-Sept;20(3):651-3. Abstract

119. van der Waal I, Axell T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol. 2002 Sept;38(6):521-6. Abstract

120. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008 Feb;37(2):63-9. Abstract

121. Schepman KP, van der Meij EH, Smeele LE, et al. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998 Jul;34(4):270-5. Abstract

122. Saito T, Sugiura C, Hirai A, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg. 2001 Feb;30(1):49-53. Abstract

123. Lodi G, Franchini R, Warnakulasuriya S, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016 Jul 29;7:CD001829.Full text  Abstract

124. Holmstrup P, Vedtofte P, Reibel J, et al. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006 May;42(5):461-74. Abstract

125. Girard KR, Strahs GR, Chung B. Panoral verrucous dysplasia: report of a case treated with split-thickness skin graft. Oral Surg Oral Med Oral Pathol. 1980 Aug;50(2):124-6. Abstract

126. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986 Dec 11;315(24):1501-5. Abstract

127. Sankaranarayanan R, Mathew B, Varghese C. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol.1997 Jul;33(4):231-6. Abstract

128. Stich HF, Hornby AP, Mathew B, et al. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett. 1988 May;40(1):93-101. Abstract

129. Elad S, Epstein JB, von Bültzingslöwen I, et al. Topical immunomodulators for management of oral mucosal conditions, a systematic review. Part II: miscellaneous agents. Expert Opin Emerg Drugs. 2011 Mar;16(1):183-202. Abstract

130. Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med. 1995;6(2):147-60. Abstract

131. Scully C, Cawson RA. Potentially malignant oral lesions. J Epidemiol Biostat. 1996;1:3-12.

132. Sciubba JJ, Helman JI. Current management strategies for verrucous hyperkeratosis and verrucous carcinoma. Oral Maxillofac Surg Clin North Am. 2013 Feb;25(1):77-82. Abstract

133. Feller L, Lemmer J. Oral leukoplakia as it relates to HPV infection: a review. Int J Dent. 2012;2012:540561.Full text  Abstract

Use of this content is subject to our disclaimer